Experimental systems that faithfully replicate human physiology at cellular, tissue and organ level are crucial to the development of efficacious and safe therapies with high success rates and low cost. The development of such systems is challenging and requires skills, expertise and inputs from a diverse range of experts, such as biologists, physicists, engineers, clinicians and regulatory bodies. Kirkstall Limited, a biotechnology company based in York, UK, organised the annual conference, Advances in Cell and Tissue Culture (ACTC), which brought together people having a variety of expertise and interests, to present and discuss the latest developments in the field of cell and tissue culture and in vitro modelling. The conference has also been influential in engaging animal welfare organisations in the promotion of research, collaborative projects and funding opportunities. This report describes the proceedings of the latest ACTC conference, which was held virtually on 30th September and 1st October 2020, and included sessions on in vitro models in the following areas: advanced skin and respiratory models, neurological disease, cancer research, advanced models including 3-D, fluid flow and co-cultures, diabetes and other age-related disorders, and animal-free research. The roundtable session on the second day was very interactive and drew huge interest, with intriguing discussion taking place among all participants on the theme of replacement of animal models of disease.
AvilaAMBebenekIBonzoJA, et al.An FDA/CDER perspective on nonclinical testing strategies: classical toxicology approaches and new approach methodologies (NAMs). Regul Toxicol Pharmacol2020; 114: 104662.
2.
PizzornoAPadeyBJulienT, et al.Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelium. Cell Rep Med2020; 1: 100059.
3.
BodaBBenaoudiaSHuangS, et al.Antiviral drug screening by assessing epithelial functions and innate immune responses in human 3D airway epithelium model. Antiviral Res2018; 156: 72–79.
CliftMJDJenkinsGJSDoakSH. An alternative perspective towards reducing the risk of engineered nanomaterials to human health. Small2020; 16: 2002002.
6.
MillerAJSpenceJR. In vitro models to study human lung development, disease and homeostasis. Physiology (Bethesda)2017; 32: 246–260.
7.
FaberSCMcCulloughSD. Through the looking glass: in vitro models for inhalation toxicology and interindividual variability in the airway. Appl In Vitro Toxicol2018; 4: 115–128.
8.
ElbertKJSchäferUFSchäfersHJ, et al.Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res1999; 16: 601–608.
9.
KuehnAKlettingSde Souza Carvalho-WodarzC, et al.Human alveolar epithelial cells expressing tight junctions to model the air–blood barrier. ALTEX2016; 33: 251–260.
10.
CostaAde Souza Carvalho-WodarzCSeabraV, et al.Triple co-culture of human alveolar epithelium, endothelium and macrophages for studying the interaction of nanocarriers with the air–blood barrier. Acta Biomater2019; 91: 235–247.
11.
Artzy-SchnirmanAZidanHElias-KirmaS, et al.Capturing the onset of bacterial pulmonary infection in acini-on-chips. Adv Biosys2019; 3: 1900026.
12.
Montefusco-PereiraCVHorstmannJCEbensenT, et al.P. aeruginosa infected 3D co-culture of bronchial epithelial cells and macrophages at air–liquid interface for preclinical evaluation of anti-infectives. J Vis Exp2020; 160: e61069.
13.
HoD-KMurgiaXDe RossiC, et al.Squalenyl hydrogen sulfate nanoparticles for simultaneous delivery of tobramycin and an alkylquinolone quorum sensing inhibitor enable the eradication of P. aeruginosa biofilm infections. Angew Chem Int Ed2020; 59: 10,292–10,296.
14.
LeiteDMZvar BaskovicBCivitaP, et al.A human co-culture cell model incorporating microglia supports glioblastoma growth and migration, and confers resistance to cytotoxics. FASEB J2020; 34: 1710–1727.
15.
CivitaPLeiteDMPilkingtonGJ. Pre-clinical drug testing in 2D and 3D human in vitro models of glioblastoma incorporating non-neoplastic astrocytes: tunneling nano tubules and mitochondrial transfer modulates cell behavior and therapeutic response. Intl J Mol Sci2019; 20: 6017.
16.
LinkousABalamatsiasDSnuderlM, et al.Modeling patient-derived glioblastoma with cerebral organoids. Cell Rep2019; 26: 3203–3211.
17.
QuailDFJoyceJA. The microenvironmental landscape of brain tumors. Cancer Cell2017; 31: 326–341.
18.
MartinSCossetECTerrandJ, et al.Caveolin-1 regulates glioblastoma aggressiveness through the control of α5β1 integrin expression and modulates glioblastoma responsiveness to SJ749, an α5β1 integrin antagonist. Biochim Biophys Acta2009; 1793: 354–367.
19.
BracherMPilkingtonGJHanemanCO, et al.A systematic approach to review of in vitro methods in brain tumour research (SAToRI-BTR): development of a preliminary checklist for evaluating quality and human relevance. Front Bioeng Biotechnol2020; 8: 936.
HartungTde VriesRHoffmannS, et al.Toward good in vitro reporting standards. ALTEX2019; 36: 3–17.
22.
MoviaDPrina-MelloA. Preclinical development of orally inhaled drugs (OIDs) — are animal models predictive or shall we move towards in vitro non-animal models?Animals2020; 10: 1259.
23.
MoviaDBazouDVolkovY, et al.Multilayered cultures of NSCLC cells grown at the air–liquid interface allow the efficacy testing of inhaled anti-cancer drugs. Sci Rep2018; 8: 12920.
24.
MoviaDBazouDPrina-MelloA. ALI multilayered co-cultures mimic biochemical mechanisms of the cancer cell-fibroblast cross-talk involved in NSCLC multidrug resistance. BMC Cancer2019; 19: 854.
25.
DuvalKGroverHHanLH, et al.Modeling physiological events in 2D vs. 3D cell culture. Physiology (Bethesda)2017; 32: 266–277.
26.
KapałczyńskaMKolendaTPrzybyłaW, et al.2D and 3D cell cultures — a comparison of different types of cancer cell cultures. Arch Med Sci2018; 14: 910–919.
27.
MandonMHuetSDubreilE, et al.Three-dimensional HepaRG spheroids as a liver model to study human genotoxicity in vitro with the single cell gel electrophoresis assay. Sci Rep2019; 9: 10548.
28.
CostaPGautrotJEConnellyJT. Directing cell migration using micropatterned and dynamically adhesive polymer brushes. Acta Biomater2014; 10: 2415–2422.
29.
BudynEGaciNSandersS, et al.Human stem cell derived osteocytes in bone-on-chip. MRS Adv2018; 3: 1443–1455.
30.
PasirayiGScottSMIslamM, et al.Low cost microfluidic cell culture array using normally closed valves for cytotoxicity assay. Talanta2014; 129: 491–498.
31.
ParekhMAliAAliZ, et al.Microbioreactor for lower cost and faster optimisation of protein production. Analyst2020; 145: 6148–6161.
32.
JohnsonBDMatherKJWallaceJP. Mechanotransduction of shear in the endothelium: basic studies and clinical implications. Vasc Med2011; 16: 365–377.
33.
CuculloLHossainMPuvennaV, et al.The role of shear stress in blood–brain barrier endothelial physiology. BMC Neurosci2011; 12: 40.
34.
ElbakaryBBadhanRKS. A dynamic perfusion based blood–brain barrier model for cytotoxicity testing and drug permeation. Sci Rep2020; 10: 3788.
35.
RinnerBGandolfiGMeditzK, et al.MUG-Mel2, a novel highly pigmented and well characterized NRAS mutated human melanoma cell line. Sci Rep2017; 7: 2098.
36.
LouYRKanninenLKuismaT, et al.The use of nanofibrillar cellulose hydrogel as a flexible three-dimensional model to culture human pluripotent stem cells. Stem Cells Dev2014; 23: 380–392.
37.
MalinenMMKanninenLKCorluA, et al.Differentiation of liver progenitor cell line to functional organotypic cultures in 3D nanofibrillar cellulose and hyaluronan-gelatin hydrogels. Biomaterials2014; 35: 5110–5121.
38.
ChenYJYamazoeTLeavensKF, et al.iPreP is a three-dimensional nanofibrillar cellulose hydrogel platform for long-term ex vivo preservation of human islets. JCI Insight2019; 4: e124644.
39.
BarnawiRAl-KhaldiSColakD, et al.β1 integrin is essential for fascin-mediated breast cancer stem cell function and disease progression. Int J Cancer2019; 145: 830–841.
40.
MarxUAnderssonTBBahinskiA, et al.Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing. ALTEX2016; 33: 272–321.
41.
JeffreyNRichardsonSBeallC, et al.The species origin of the cellular microenvironment influences markers of beta cell fate and function in EndoC-βH1 cells. Exp Cell Res2017; 361: 284–291.
42.
TottiSAllebyMCSantosSBD, et al.A 3D bioinspired highly porous polymeric scaffolding system for in vitro simulation of pancreatic ductal adenocarcinoma. RSC Adv2018; 8: 20,928–20,940.
43.
GuptaPTottiSPerez-ManceraPA, et al.Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. RSC Adv2019; 9: 41,469–41,663.
44.
GuptaPPerez-ManceraPAKocherH, et al.A novel scaffold-based hybrid multicellular model for pancreatic ductal adenocarcinoma — toward a better mimicry of the in vivo tumor microenvironment. Front Bioeng Biotechnol2020; 8: 290.
45.
GrumettoLMontesanoDSecciaS, et al.Determination of bisphenol A and bisphenol B residues in canned peeled tomatoes by reversed-phase liquid chromatography. J Agric Food Chem2008; 56: 10,633–10,637.
46.
LeHHCarlsonEMChuaJP, et al.Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol Lett2008; 176: 149–156.
47.
CooperJEKendigELBelcherSM. Assessment of bisphenol A released from reusable plastic, aluminium and stainless steel water bottles. Chemosphere2011; 85: 943–947.
48.
Diamanti-KandarakisEBourguignonJPGiudiceLC, et al.Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev2009; 30: 293–342.
49.
MaconMBFentonSE. Endocrine disruptors and the breast: early life effects and later life disease. J Mammary Gland Biol Neoplasia2013; 18: 43–61.
50.
GoreACChappellVAFentonSE, et al.Executive summary to EDC-2: the Endocrine Society’s second scientific statement on endocrine-disrupting chemicals. Endocr Rev2015; 36: 593–602.
51.
WuQLiBLiZ, et al.Cancer-associated adipocytes: key players in breast cancer progression. J Hematol Oncol2019; 12: 95.
52.
MarinoNGermanRRaoX, et al.Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis. NPJ Breast Cancer2020; 6: 50.
53.
LakhinAVTarantulVZGeningLV. Aptamers: problems, solutions and prospects. Acta Naturae2013; 5: 34–43.
54.
OdehFNsairatHAlshaerW, et al.Aptamers chemistry: chemical modifications and conjugation strategies. Molecules2020; 25: 3.
55.
ClarkeRMonaghanKAboutI, et al.TRPA1 activation in a human sensory neuronal model: relevance to cough hypersensitivity?Eur Respir J2017; 50: 1700995.
56.
KostrzewskiTMaraverPOuro-GnaoL, et al.A microphysiological system for studying nonalcoholic steatohepatitis. Hepatol Commun2020; 4: 77–91.
57.
KostrzewskiTCornforthTSnowSA, et al.Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease. World J Gastroenterol2017; 23: 204–215.
58.
VaccaMLeslieJVirtueS, et al.Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis. Nat Metab2020; 2: 514–531.
59.
MetzJKWiegandBSchnurS, et al.Modulating the barrier function of human alveolar epithelial (hAELVi) cell monolayers as a model of inflammation. Altern Lab Anim2020; 48: 252–267.
60.
KopanskaKSRimannMLatenserS, et al.Advanced in vitro models analysis. ALTEX2019; 36: 144–147.
61.
PaulSMMytelkaDSDunwiddieCT, et al.How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov2010; 9: 203–214.
